Optimizing the Temperature for Embryo Culture in In Vitro Fertilization
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
Many human and animal studies over the past 40 years have revealed that ovaries and Fallopian tubes have a lower temperature than core body temperature, especially around the time of ovulation and early embryo development. Whether average core body temperature, 37 degrees Celsius, is ideal temperature for culture has not been prospectively evaluated. The purpose of this study is to determine whether lowering the incubator temperature by 1 degree Celsius will result in meaningful improvements in embryo development and pregnancy rates.
Patients participating in this study will undergo routine in vitro fertilization (IVF) stimulation. Following egg retrieval, patients with at least 8 mature eggs will have those eggs divided randomly into two groups. Both groups will then under ICSI (intra-cytoplasmic sperm injection) to fertilize the eggs. The groups will randomly be assigned to control or study condition. The control condition group will be cultured at 37 degrees Celsius, the current standard of care. The study group will be cultured at 36 degrees Celsius. All other culture conditions will be kept identical and embryos will be assessed on day 3 and day 5 of development.
On day 5, all well-developed blastocysts will undergo biopsy for Comprehensive Chromosomal Screening (CCS), which will evaluate the chromosomal normalcy of the embryo . Patients will undergo transfer on the morning of day 6 and the highest quality, chromosomally normal embryo from each group (the 36 degree cultured embryos and the 37 degree cultured embryos) will be transferred. If only 1 embryo is available for transfer, the patient will have a single embryo transfer.
All embryos available for cryopreservation will undergo biopsy for CCS before being frozen. Some arrested embryos from each temperature group will also undergo genetic analysis to evaluate chromosomal normalcy or mosaicism.
The female patient will undergo a blood draw at 9 weeks gestation and buccal swabs will be obtained from the infant(s) after birth.
| Condition | Intervention |
|---|---|
|
Infertility |
Other: 36 degrees Celsius |
| Study Type: | Interventional |
| Study Design: | Allocation: Randomized Endpoint Classification: Safety/Efficacy Study Intervention Model: Parallel Assignment Masking: Open Label |
| Official Title: | Optimizing the Temperature for Embryo Culture in In Vitro Fertilization: A Randomized Controlled Trial |
- Useable Blastocyst Formation Rate [ Time Frame: approximately 1 week ] [ Designated as safety issue: No ]Proportion of mature eggs developing into expanded blastocysts (Gardner grade 3-6) of sufficient quality to transfer or cryopreserve will be documented for each group (36 degree and 37 degree group).
- Fertilization rate [ Time Frame: approximately 2 days ] [ Designated as safety issue: No ]The proportion of mature eggs that underwent ICSI and are normally fertlized (documented as forming 2 pro-nuclei (2PNs)) on the day after egg retrieval will be documented for each group (36 degree and 37 degree groups)
- Cleavage Rate [ Time Frame: approximately 1 week ] [ Designated as safety issue: No ]Proportion of properly fertlized embryo (2PNs on day 1) that undergo further celluar division will be documented for each group (36 degree and 37 degree group).
- Blastocyst Formation Rate [ Time Frame: approximately 1 week ] [ Designated as safety issue: No ]Proportion of mature oocytes that go on to develop into blastocysts in each group (36 degree group and 37 degree group) will be documented.
- Implantation Rate [ Time Frame: approximately 2 weeks ] [ Designated as safety issue: No ]Proportion of transferred embryos resulting in a clinically documented pregnancy will be documented for each group (36 degree and 37 degree group).
- Aneuploidy Rate [ Time Frame: approximately 1 month ] [ Designated as safety issue: No ]Rate of chromosomal abnormalities among the embryos in each group (36 degree and 37 degree groups) as determined by polymerase chain reaction (PCR) based comprehensive chromosome screening (CCS).
- Mosaicism Rate [ Time Frame: approximately 1 month ] [ Designated as safety issue: No ]Proportion of embryos that arrest at the cleavage stage which show evidence of more than one chromosomal lineages (mosaicism) when analyzed my microarray documented in each group (36 degree and 37 degree group).
| Estimated Enrollment: | 100 |
| Study Start Date: | January 2012 |
| Estimated Study Completion Date: | January 2014 |
| Estimated Primary Completion Date: | January 2013 (Final data collection date for primary outcome measure) |
| Arms | Assigned Interventions |
|---|---|
|
Experimental: 36 degree group
36 degrees Celsius for the incubators is the experimental condition in this study.
|
Other: 36 degrees Celsius
Embryos in this group will be cultured in incubators set to 36 degrees Celsius.
Other Name: IVF, PGD, embryos, culture, CCS, infertility
|
|
No Intervention: 37 degree group
37 degrees Celsius is the standard incubator temperature for the culture of embryos.
|
Eligibility| Ages Eligible for Study: | 18 Years to 41 Years |
| Genders Eligible for Study: | Female |
| Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
- No more than 1 prior failed cycle at RMA NJ facility; up to 2 prior failed cycles at another facility pending investigator review
- Female partner between 18 and 41 at onset of IVF cycle
- Normal day 3 FSH (< or = 12) in RMA NJ laboratory
- Basal antral follicle count of at least 10
- Male partner with greater than 100,000 total motile spermatozoa per ejaculate (donor sperm is ok)
- BMI < or = 32 kg/m2
Exclusion Criteria:
- Diagnosis of chronic anovulation (cycles occuring typically less often than every 90 days)
- Use of testicular aspiration or biopsy procedures to obtain sperm
- Unevaluated ovarian mass or diagnosis of surgically-confirmed stage IV endometriosis
- Presence of hydrosalpinges that communicate with the uterine cavity
- History of endometrial insufficiency
- Any contraindication to undergoing IVF or gonadotropin stimulation
- Prior poor fertilization rate- less than 50% of mature eggs
- Prior poor blastulation rate- less than 10% of 2PNs (day 1 embryos)
Contacts and Locations| United States, New Jersey | |
| Reproductive Medicine Associates of New Jersey | |
| Morristown, New Jersey, United States, 07960 | |
| United States, Pennsylvania | |
| Reproductive Medicine Associates of Pennsylvannia | |
| Allentown, Pennsylvania, United States, 18104 | |
| Principal Investigator: | Richard T Scott, MD | Reproductive Medicine Associates of New Jersey |
More Information
Additional Information:
No publications provided
| Responsible Party: | Reproductive Medicine Associates of New Jersey |
| ClinicalTrials.gov Identifier: | NCT01506089 History of Changes |
| Other Study ID Numbers: | RMA-2011-02 |
| Study First Received: | January 3, 2012 |
| Last Updated: | January 22, 2013 |
| Health Authority: | United States: Institutional Review Board |
Keywords provided by Reproductive Medicine Associates of New Jersey:
|
IVF infertility PGD embryo temperature |
incubator CCS culture incubator-36 degrees Celsius incubator-37 degrees Celsius |
Additional relevant MeSH terms:
|
Infertility Genital Diseases, Male Genital Diseases, Female |
ClinicalTrials.gov processed this record on May 16, 2013